# Efficacy of Ivermectin in Outpatients With Non-severe COVID-19

> **NCT04834115** · PHASE3 · UNKNOWN · sponsor: **Universidad Nacional de Asunción** · enrollment: 400 (estimated)

## Conditions studied

- Covid19
- Coronavirus Infection

## Interventions

- **DRUG:** Ivermectin Tablets
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04834115
- **Lead sponsor:** Universidad Nacional de Asunción
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-11-17
- **Primary completion:** 2021-04-30
- **Final completion:** 2021-05-30
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2021-04-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04834115

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04834115, "Efficacy of Ivermectin in Outpatients With Non-severe COVID-19". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04834115. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*